清毒化瘀汤联合羟基脲治疗慢性粒细胞白血病疗效观察  

Effective observation on treating chronic myeloid leukemia with Qingdu Huayu decoction plus hydroxyurea

作　　者：王明松[1] 

机构地区：[1]山东省临沂市沂水中心医院,山东临沂276400

出　　处：《中医临床研究》2011年第5期44-45,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨清毒化瘀汤联合羟基脲治疗慢性粒细胞白血病的疗效。方法:回顾性分析我院2008年6月至2010年5月收治的46例慢性粒细胞白血病患者的临床资料,分组成2组治疗,治疗组采用清毒化淤汤联合羟基脲进行治疗;对照组则未采用清毒化淤汤。并对两组结果进行对照分析。结果:治疗组24例中,6年的缓解生存率为完全缓解(CR)17例,部分缓解(PR)4例,无缓解(NR)3例;对照组22例中,CR为8例、PR为4例和NR为10例。治疗组疗效优于对照组(P<0.05)。结论:临床结果证明采用清毒化淤汤联合羟基脲治疗慢性粒细胞白血病药效更佳,不良反映也低于对照组,且能有效延长生存期,提高生存质量。Objective： To investigate the therapy on treating chronic myeloid leukemia with Qingdu Huayu decoction plus hydroxyurea. Methods： To analyze the clinical information of the 46 patients who with chronic myeloid leukemia in our hospital from June 2008 to May 2010, divide them into into 2 groups, the treatment group was treated by disinfection stasis soup plus hydroxyurea; The control group weren＇t treated by Qingdu Huayu decoction plus hydroxyurea. Results： Among the 24 cases of he treatment group, 6-year catabatic survival rate of complete remission （CR） was 17 cases, part catabatic （PR） 4 for cases, no relief （NR） for 3 patients, 22 cases among the control group, CR for 8 cases, PR for 4 cases and NR for 10 cases. The therapy of the treatment group was better than the control group （P〈0.05）. Conclusion： Clinical results proved that treating chronic myeloid leukemia with Qingdu Huayu deQocti0n plus hydroxyurea, is better, adverse reflection is also lower than the control group, and also can prolong the survival, improve the quality of life.

关 键 词：中西医结合治疗 慢性粒细胞性白血病 清毒化瘀汤 中医药疗法羟基脲 

分 类 号：R733.7[医药卫生—肿瘤]